BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 7006782)

  • 1. Developing ways of reducing allograft immunogenicity.
    Guttmann RD
    Can Med Assoc J; 1981 Jan; 124(2):143-5. PubMed ID: 7006782
    [No Abstract]   [Full Text] [Related]  

  • 2. Donor pretreatment in an unselected series of cadaver renal allografts.
    Guttmann RD; Morehouse DD; Meakins JL; Klassen J; Knaack J; Beaudoin JG
    Kidney Int Suppl; 1978 Jun; (8):S99-102. PubMed ID: 357821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of donor pretreatment prolongs canine renal allograft survival.
    Dienst SG; MacDonald R; Toledo-Pereyra LH; Fox B
    Transplant Proc; 1979 Jun; 11(2):1465-6. PubMed ID: 382541
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal transplantation in the inbred rat. 18. Effect of cyclophosphamide on acute rejection and long survival of recipients.
    Kawabe K; Guttmann RD; Levin B; Merrill JP; Lindquist RR
    Transplantation; 1972 Jan; 13(1):21-6. PubMed ID: 4550343
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination drug treatment in immunosuppression. Effect of azathioprine, cyclophosphamide, and methylprednisolone on rabbit renal allografts.
    Friedman EA; Ueno A; Beyr MM; Nicastri AD
    Transplantation; 1973 Jun; 15(6):619-23. PubMed ID: 4577157
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic comparisons of isolated pancreatic islet and whole-organ allografts.
    Reckard CR; Stuart FP; Schulak JA
    Transplant Proc; 1979 Mar; 11(1):563-6. PubMed ID: 109968
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of procarbazine hydrochloride versus cyclophosphamide in donor pretreatment in cadaveric renal transplantation.
    Zincke H; Woods JE; Roses J; Kimbler RW
    Mayo Clin Proc; 1976 Nov; 51(11):693-6. PubMed ID: 792579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin a: a new era in organ transplantation.
    DeBakey ME
    Compr Ther; 1984 Feb; 10(2):7-15. PubMed ID: 6368108
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal allograft survival in bone marrow chimeras.
    Hussey JL; Daouk A; Elhabashi S; Kisken WA
    Surg Forum; 1971; 22():233-5. PubMed ID: 4399270
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunosuppressive effect of histone on the model of skin transplantation. Comparative studies with cyclophosphamide].
    Gillissen G
    Z Gesamte Exp Med Einschl Exp Chir; 1970 Aug; 152(4):335-51. PubMed ID: 4930364
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolongation of canine allograft survival with donor pretreatment.
    Brom HL; van Breda Vriesman PJ; Terpstra JL
    Kidney Int; 1982 Feb; 21(2):323-9. PubMed ID: 6803060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin and renal rabbit allograft rejection following large pulse doses of methylprednisolone.
    Friedman EA; Beyer MM
    Transplant Proc; 1975 Mar; 7(1):67-72. PubMed ID: 1091047
    [No Abstract]   [Full Text] [Related]  

  • 13. Manipulation of allograft immunogenicity by pretreatment of cadaver donors.
    Guttmann RD
    Urol Clin North Am; 1976 Oct; 3(3):475-90. PubMed ID: 790729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor pretreatment on perfused cadaver kidneys: experimental observations.
    Sy G; Taiyebb S; Toledo-Pereyra LH
    Am Surg; 1981 Jul; 47(7):307-8. PubMed ID: 7020513
    [No Abstract]   [Full Text] [Related]  

  • 15. [The immunogenicity of different organs and the characteristics of immunosuppressive therapy during their allotransplantation].
    Kiprenskiĭ IuV; Erofeev GP
    Khirurgiia (Mosk); 1992 Mar; (3):123-32. PubMed ID: 1434354
    [No Abstract]   [Full Text] [Related]  

  • 16. [Improvement of the results of renal transplantation by the use of antilymphocyte globulin (ALG)].
    Renna E; Alfani D; Monari C; Trovati A; Berloco P; Famulari A; Cucchiara G; Cortesini R
    Minerva Chir; 1980 May; 35(10):747-50. PubMed ID: 7005730
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of ionizing radiation in transplantation.
    van Bekkum DW
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):59-65. PubMed ID: 4155159
    [No Abstract]   [Full Text] [Related]  

  • 18. A histological technique for assaying the efficacy of methods designed to reduce allograft rejection.
    Stewart PA; Swinney J
    Br J Surg; 1972 Apr; 59(4):312. PubMed ID: 4553602
    [No Abstract]   [Full Text] [Related]  

  • 19. The enhancing effect of donor pretreatment and low dose immunosuppression in dogs.
    Swistel AJ; McCabe RE; Lorieo DR; Wildstein A; Pierce JC; Fitzpatrick HF
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():93-5. PubMed ID: 386328
    [No Abstract]   [Full Text] [Related]  

  • 20. Improved survival after donor pretreatment with anti-lymphoblast globulin (ALG) in perfused kidneys: experimental findings.
    Toledo-Pereyra LH; Taiyebb S; McKenzie GH; Gordon DA; Sy GS
    J Surg Res; 1981 Aug; 31(2):172-7. PubMed ID: 7022024
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.